These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2340442)

  • 1. Oxypurinol limits myocardial infarct size in closed chest dogs without pretreatment.
    Matsuki T; Shirato C; Cohen MV; Downey JM
    Can J Cardiol; 1990 Apr; 6(3):123-9. PubMed ID: 2340442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial salvage with allopurinol during 24 h of permanent coronary occlusion: importance of pretreatment.
    Kingma JG; Miura T; Downey JM; Hearse DJ; Yellon DM
    Can J Cardiol; 1988 Oct; 4(7):360-5. PubMed ID: 3228762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs.
    Vander Heide RS; Reimer KA
    Cardiovasc Res; 1996 May; 31(5):711-8. PubMed ID: 8763400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limitation of infarct size for 24 hours by combined treatment with allopurinol plus verapamil during acute myocardial infarction in the dog.
    Kingma JG; Denniss AR; Hearse DJ; Downey JM; Yellon DM
    Circulation; 1987 Jun; 75(6 Pt 2):V25-33. PubMed ID: 3568337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The xanthine oxidase inhibitor oxypurinol does not limit infarct size in a canine model of 40 minutes of ischemia with reperfusion.
    Kinsman JM; Murry CE; Richard VJ; Jennings RB; Reimer KA
    J Am Coll Cardiol; 1988 Jul; 12(1):209-17. PubMed ID: 3379207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxypurinol limits myocardial stunning but does not reduce infarct size after reperfusion.
    Puett DW; Forman MB; Cates CU; Wilson BH; Hande KR; Friesinger GC; Virmani R
    Circulation; 1987 Sep; 76(3):678-86. PubMed ID: 3621527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog.
    Mizumura T; Nithipatikom K; Gross GJ
    Cardiovasc Res; 1995 Apr; 29(4):482-9. PubMed ID: 7796441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size.
    Reimer KA; Jennings RB
    Lab Invest; 1984 Dec; 51(6):655-66. PubMed ID: 6503220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clentiazem given at reperfusion improves subendocardial reflow and reduces myocardial infarct size in the dog.
    Rousseau G; Provost P; Tran D; Caillé G; Latour JG
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1252-60. PubMed ID: 8138938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verapamil and nifedipine limit infarct size in the dog.
    Downey JM; Hearse DJ; Yoshida S; Maxwell MP; Yellon DM
    Adv Myocardiol; 1985; 6():529-43. PubMed ID: 3992049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preischaemic as well as postischaemic application of a Na+/H+ exchange inhibitor reduces infarct size in pigs.
    Rohmann S; Weygandt H; Minck KO
    Cardiovasc Res; 1995 Dec; 30(6):945-51. PubMed ID: 8746210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term inhibition of myocardial infarction by postconditioning during reperfusion.
    Mykytenko J; Kerendi F; Reeves JG; Kin H; Zatta AJ; Jiang R; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Basic Res Cardiol; 2007 Jan; 102(1):90-100. PubMed ID: 17003965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotigaptide (ZP123) prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogs.
    Hennan JK; Swillo RE; Morgan GA; Keith JC; Schaub RG; Smith RP; Feldman HS; Haugan K; Kantrowitz J; Wang PJ; Abu-Qare A; Butera J; Larsen BD; Crandall DL
    J Pharmacol Exp Ther; 2006 Apr; 317(1):236-43. PubMed ID: 16344331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration and reinstatement of myocardial protection against infarction by ischemic preconditioning in open chest dogs.
    Schwartz LM; Sebbag L; Jennings RB; Reimer KA
    J Mol Cell Cardiol; 2001 Sep; 33(9):1561-70. PubMed ID: 11549337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contraction band necrosis: its modification by the free radical scavenger N-2-mercaptopropionyl glycine.
    Widman SC; Liang CS; Schenk EA; Hood WB
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):694-701. PubMed ID: 7532745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infarct-size limitation--real or artifactual. Studies with flurbiprofen using a reperfusion model.
    Yellon DM; Maxwell MP; Hearse DJ; Yoshida S; Eddy L; Downey JM
    Adv Myocardiol; 1985; 6():619-27. PubMed ID: 3992053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function.
    Schaer GL; Hursey TL; Abrahams SL; Buddemeier K; Ennis B; Rodriguez ER; Hubbell JP; Moy J; Parrillo JE
    Circulation; 1994 Dec; 90(6):2964-75. PubMed ID: 7994844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infarct size limitation by the xanthine oxidase inhibitor, allopurinol, in closed-chest dogs with small infarcts.
    Akizuki S; Yoshida S; Chambers DE; Eddy LJ; Parmley LF; Yellon DM; Downey JM
    Cardiovasc Res; 1985 Nov; 19(11):686-92. PubMed ID: 3841027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanthine oxidase inhibition does not limit canine infarct size.
    Werns SW; Grum CM; Ventura A; Hahn RA; Ho PP; Towner RD; Fantone JC; Schork MA; Lucchesi BR
    Circulation; 1991 Mar; 83(3):995-1005. PubMed ID: 1999047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A useful canine model of ischemic myocardium with coronary retrograde flow diversion, and its application for the study of allopurinol on myocardial infarct size.
    Motoe M; Yoshida S
    Jpn Circ J; 1991 May; 55(5):490-9. PubMed ID: 2062000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.